MedTrace Logo

NIRS in PDA VLBW Infants

NCT02396004 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2017-02-10

No results posted yet for this study

Summary

Aim of study:

To conduct an observational study to collect cerebral and renal perfusion data through NIRS before and after treatment of PDA by medication or by PDA ligation. The data post treatment would form the basis for normative baseline data in VLBW preterm newborn babies, particularly in the Asian population.

Study population/inclusion criteria:

VLBW newborn babies with hemodynamically significant PDA by echocardiography.

Exclusion criteria:

Major malformations Moribund patients

Conditions

  • PDA

Interventions

DEVICE

Near Infrared Red Spectroscopy (NIRS)

NIRS using INVOS cerebral/somatic oximeter

Sponsors & Collaborators

  • Singapore General Hospital

    lead OTHER

Principal Investigators

  • Woei Bing Poon, MRCPCH · Singapore General Hospital

Eligibility

Max Age
6 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02396004 on ClinicalTrials.gov